This thought-provoking collection of essays��ritten in celebration of Putnam Associates' twentieth anniversary��xplores the impact that globalization, changing risk profiles, generics, and
managed care have had on the healthcare and bio-pharmaceutical industries over the last two decades. Written from a variety of professional perspectives, The First Twenty Years Are the Hardest
demonstrates the complex interdependencies of the U.S. healthcare system and sheds light on the process of developing and marketing new therapies. With unflinching honesty and analytic rigor,
the triumphs, failures, and challenges of the industry are examined.
